MedPath

Optical Quality After Implantation of a Spherical or Aspherical Intraocular Lens in Hypermetropic Patients

Not Applicable
Completed
Conditions
Cataract
Depth of Focus
Spherical Aberrations
Intraocular Lenses
Registration Number
NCT01995630
Lead Sponsor
Medical University of Graz
Brief Summary

The purpose of this study is to evaluate differences in the depth of focus after implantation of a spherical or aspheric IOL in hypermetropic and emmetropic patients. After implantation of a spherical IOL hypermetropic patients may achieve a better depth of focus compared to emmetropic patients due to a larger amount of spherical aberrations.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
62
Inclusion Criteria
  • Cataract
  • Dioptric power of IOL >22.0 D in hypermetropic patients and 18.0-22.0 D in emmetropic patients, respectively
Exclusion Criteria
  • Uveitis, pathology of the retina or the optic nerve
  • Corneal scarring or irregularities
  • Astigmatism >1.5 D
  • Amblyopia
  • Perioperative complications
  • Postoperative refractive error >2.0 D of spherical equivalent
  • Postoperative DCVA <0.8 (ETDRS)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Distance-corrected intermediate visual acuity3 month postop
Secondary Outcome Measures
NameTimeMethod
Pseudoaccomodation3 month postop
Photopic contrast sensitivity3 month postop
Distance-corrected near visual acuity3 month postop
Uncorrected distance visual acuity3 month postop
Corrected distance visual acuity3 month postop
Uncorrected near visual acuity3 month postop
Corrected near visual acuity3 month postop
Mesopic contrast sensitivity3 month postop
Spherical aberrations3 month postop
High order aberrations3 month postop

Trial Locations

Locations (1)

Dept. of Ophthalmology, Medical University of Graz

🇦🇹

Graz, Austria

Dept. of Ophthalmology, Medical University of Graz
🇦🇹Graz, Austria

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.